APH vs BVS · P/E 40, rev $23.09B vs rev $573.3M
Amphenol Corporation (APH) versus Bioventus Inc (BVS) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Bioventus Inc (BVS) is a medical devices company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. BVS currently screens at market cap $495.1M.
Not investment advice. Open the APH and BVS stock pages for the full models.
Not investment advice.